Additional file 6 of Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer

Additional file 6: sFigure 6. The correlation among DIP2B expression with immunostimulator related genes and immunoinhibitor related genes and chemokine receptor related genes in pan-cancer. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001

Additional file 2 of Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer

Additional file 2: sFigure 2. The expression of DIP2B in CCLE tumor cell line

Additional file 1 of Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer

Additional file 1: sFigure 1. The flow chart of the present study

Additional file 7 of Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer

Additional file 7: sFigure 7. The correlation among DIP2B expression with immunostimulator related genes and immunoinhibitor related genes and chemokine receptor related genes in subtypes of BRCA. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001

Additional file 8 of Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer

Additional file 8: sFigure 8. Original Western blots pictures. A: DIP2B; B: GAPDH

Additional file 3 of Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer

Additional file 3: sFigure 3. The relationship between expression of DIP2B and tumor stage in 19 cancer types

Additional file 4 of Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer

Additional file 4: sFigure 4. The relationship between expression of DIP2B and overall survival in pancancer

Additional file 5 of Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer

Additional file 5: sFigure 5. The relationship between expression of DIP2B and subtypes of immune infiltration cells in pancancer

RNF146 regulated cell proliferation of lung cancer cells.

<p>(A) MTT cell proliferation assay with overexpression of RNF146 and shRNA-mediated knockdown of RNF146. **<i>P</i><0.05. (B) Effects of RNF146 on cell cycle analyzed by flow cytometry. (C) Detecting cell cycle protein expression by Western blot.</p

Correlation of RNF146 and Axin and β-catenin expression in NSCLC tumors.

<p>Correlation of RNF146 and Axin and β-catenin expression in NSCLC tumors.</p